Zobrazeno 1 - 10
of 7 670
pro vyhledávání: '"Urobilin"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kipp ZA; Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, USA., Badmus OO; Department of Physiology and Biophysics, Cardiorenal, and Metabolic Diseases Research Center, University of Mississippi Medical Center, Jackson, MS, USA., Stec DE; Department of Physiology and Biophysics, Cardiorenal, and Metabolic Diseases Research Center, University of Mississippi Medical Center, Jackson, MS, USA., Hall B; Center for Bioinformatics and Computational Biology, Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, College Park, MD, USA., Hinds TD Jr; Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, USA. Electronic address: Terry.Hinds@uky.edu.
Publikováno v:
Metabolism: clinical and experimental [Metabolism] 2024 Nov 22; Vol. 163, pp. 156081. Date of Electronic Publication: 2024 Nov 22.
Autor:
Bates, Evelyn A.1 (AUTHOR), Kipp, Zachary A.1 (AUTHOR), Martinez, Genesee J.1 (AUTHOR), Badmus, Olufunto O.2 (AUTHOR), Soundarapandian, Mangala M.3 (AUTHOR), Foster, Donald3 (AUTHOR), Xu, Mei1 (AUTHOR), Creeden, Justin F.4 (AUTHOR), Greer, Jennifer R.2 (AUTHOR), Morris, Andrew J.5 (AUTHOR), Stec, David E.2 (AUTHOR) dstec@umc.edu, Hinds Jr., Terry D.1,6,7 (AUTHOR) dstec@umc.edu
Publikováno v:
Biomolecules (2218-273X). Feb2023, Vol. 13 Issue 2, p252. 19p.
Autor:
Prakash S; Department of Chemistry, Indian Institute of Technology Madras, Chennai 600036, India. mishra@iitm.ac.in., Mishra AK; Department of Chemistry, Indian Institute of Technology Madras, Chennai 600036, India. mishra@iitm.ac.in.
Publikováno v:
Analytical methods : advancing methods and applications [Anal Methods] 2021 Dec 02; Vol. 13 (46), pp. 5573-5588. Date of Electronic Publication: 2021 Dec 02.
Autor:
Prakash S; Department of Chemistry, IIT Madras, Chennai, India., Panigrahi SK; Department of Chemistry, IIT Madras, Chennai, India., Dorner RP; Technologiezentrum Wasser (TZW), Dresden, Germany., Wagner M; Technologiezentrum Wasser (TZW), Dresden, Germany., Schmidt W; Technologiezentrum Wasser (TZW), Dresden, Germany., Mishra AK; Department of Chemistry, IIT Madras, Chennai, India. Electronic address: mishra@iitm.ac.in.
Publikováno v:
Chemosphere [Chemosphere] 2021 Feb; Vol. 265, pp. 129189. Date of Electronic Publication: 2020 Dec 08.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Antioxidants, Vol 12, Iss 1, p 170 (2023)
Bilirubin levels in obese humans and rodents have been shown to be lower than in their lean counterparts. Some studies have proposed that the glucuronyl UGT1A1 enzyme that clears bilirubin from the blood increases in the liver with obesity. UGT1A1 cl
Externí odkaz:
https://doaj.org/article/dcd8e3fc17c74fd6b1a20786aac96bdd
Autor:
Chedekel, M., Bovey, F. A., Brewster, A. I. R., Petryka, Z. J., Weimer, M., Watson, C. J., Moscowitz, Albert, Lightner, D. A.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1974 May 01. 71(5), 1599-1601.
Externí odkaz:
https://www.jstor.org/stable/63482
Autor:
Evelyn A. Bates, Zachary A. Kipp, Genesee J. Martinez, Olufunto O. Badmus, Mangala M. Soundarapandian, Donald Foster, Mei Xu, Justin F. Creeden, Jennifer R. Greer, Andrew J. Morris, David E. Stec, Terry D. Hinds
Publikováno v:
Biomolecules, Vol 13, Iss 2, p 252 (2023)
Several population studies have observed lower serum bilirubin levels in patients with non-alcoholic fatty liver disease (NAFLD). Yet, treatments to target this metabolic phenotype have not been explored. Therefore, we designed an N-Acetylgalactosami
Externí odkaz:
https://doaj.org/article/d673bff3a31949f9babcc166e038f8be